Migration of encephalitogenic CD8 T cells into the central nervous system is dependent on the α4β1-integrin

European Journal of Immunology

Volumn 45, Issue 12, 2015, Pages 3302-3312

  Martin Blondel, Guillaume ^a,b,c   Pignolet, Béatrice ^a,b,c   Tietz, Silvia ^d   Yshii, Lidia ^b,c   Gebauer, Christina ^b,c   Perinat, Therese ^d   Van Weddingen, Isabelle ^b   Blatti, Claudia ^d   Engelhardt, Britta ^d   Liblau, Roland ^b,c  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b University of Toulouse III   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

CD8 T cell; Junctional adhesion molecule B; Migration; Neuroinflammation; 4 1 Integrin

Indexed keywords

CD31 ANTIGEN; CD44V ANTIGEN; GAMMA INTERFERON; HEMAGGLUTININ; HETERODIMER; IMMUNOGLOBULIN G; JUNCTIONAL ADHESION MOLECULE B; L SELECTIN; RECOMBINANT INTERCELLULAR ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4; CELL ADHESION MOLECULE; JAM2 PROTEIN, MOUSE;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; BINDING ASSAY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CENTRAL NERVOUS SYSTEM; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES INSIPIDUS; DISEASE SEVERITY; ENDOTHELIUM; ENDOTHELIUM CELL; EX VIVO STUDY; FLOW CYTOMETRY; HISTOPATHOLOGY; IN VITRO STUDY; INFLAMMATORY INFILTRATE; LYMPHOCYTE MIGRATION; LYMPHOCYTIC INFILTRATION; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T CELL DEPLETION; TISSUE INJURY; WEIGHT REDUCTION; ANIMAL; BAGG ALBINO MOUSE; BRAIN; C57BL MOUSE; CELL MOTION; CYTOLOGY; ENCEPHALOMYELITIS; IMMUNOLOGY; MICROGLIA; PHYSIOLOGY;

ANIMALS; BRAIN; CD8-POSITIVE T-LYMPHOCYTES; CELL ADHESION MOLECULES; CELL MOVEMENT; ENCEPHALOMYELITIS; INTEGRIN ALPHA4BETA1; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICROGLIA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84952639064     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201545632     Document Type: Article

References (56)

1. Galea, I., Bechmann, I. and Perry, V. H., What is immune privilege (not)? Trends Immunol. 2007. 28: 12-18.
2. Liblau, R. S., Gonzalez-Dunia, D., Wiendl, H. and Zipp, F., Neurons as targets for T cells in the nervous system. Trends Neurosci. 2013. 36: 315-324.
3. Wilson, E. H., Weninger, W. and Hunter, C. A., Trafficking of immune cells in the central nervous system. J. Clin. Invest. 2010. 120: 1368-1379.
4. Engelhardt, B. and Ransohoff, R. M., Capture, crawl, cross: the T cell code to breach the blood-brain barriers. Trends Immunol. 2012. 33: 579-589.
5. Bartholomaus, I., Kawakami, N., Odoardi, F., Schlager, C., Miljkovic, D., Ellwart, J. W., Klinkert, W. E. et al., Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature 2009. 462: 94-98.
6. Bauer, M., Brakebusch, C., Coisne, C., Sixt, M., Wekerle, H., Engelhardt, B. and Fassler, R., Beta1 integrins differentially control extravasation of inflammatory cell subsets into the CNS during autoimmunity. Proc. Natl. Acad. Sci. USA 2009. 106: 1920-1925.
7. Engelhardt, B., Laschinger, M., Schulz, M., Samulowitz, U., Vestweber, D. and Hoch, G., The development of experimental autoimmune encephalomyelitis in the mouse requires alpha4-integrin but not alpha4beta7-integrin. J. Clin. Invest. 1998. 102: 2096-2105.
8. Vajkoczy, P., Laschinger, M. and Engelhardt, B., Alpha4-integrin-VCAM-1 binding mediates G protein-independent capture of encephalitogenic T cell blasts to CNS white matter microvessels. J. Clin. Invest. 2001. 108: 557-565.
9. Yednock, T. A., Cannon, C., Fritz, L. C., Sanchez-Madrid, F., Steinman, L. and Karin, N., Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 1992. 356: 63-66.
10. Rothhammer, V., Muschaweckh, A., Gasteiger, G., Petermann, F., Heink, S., Busch, D. H., Heikenwalder, M. et al., Alpha4-integrins control viral meningoencephalitis through differential recruitment of T helper cell subsets. Acta Neuropathol. Commun. 2014. 2: 27.
11. Rothhammer, V., Heink, S., Petermann, F., Srivastava, R., Claussen, M. C., Hemmer, B. and Korn, T., Th17 lymphocytes traffic to the central nervous system independently of alpha4 integrin expression during EAE. J. Exp. Med. 2011. 208: 2465-2476.
12. Martin-Blondel, G., Delobel, P., Blancher, A., Massip, P., Marchou, B., Liblau, R. S. and Mars, L. T., Pathogenesis of the immune reconstitution inflammatory syndrome affecting the central nervous system in patients infected with HIV. Brain 2011. 134: 928-946.
13. Saxena, A., Martin-Blondel, G., Mars, L. T. and Liblau, R. S., Role of CD8 T cell subsets in the pathogenesis of multiple sclerosis. FEBS Lett. 2011. 585: 3758-3763.
14. Bien, C. G., Vincent, A., Barnett, M. H., Becker, A. J., Blumcke, I., Graus, F., Jellinger, K. A. et al., Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain 2012. 135: 1622-1638.
15. Battistini, L., Piccio, L., Rossi, B., Bach, S., Galgani, S., Gasperini, C., Ottoboni, L. et al., CD8+ T cells from patients with acute multiple sclerosis display selective increase of adhesiveness in brain venules: a critical role for P-selectin glycoprotein ligand-1. Blood 2003. 101: 4775-4782.
16. Cayrol, R., Wosik, K., Berard, J. L., Dodelet-Devillers, A., Ifergan, I., Kebir, H., Haqqani, A. S. et al., Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system. Nat. Immunol. 2008. 9: 137-145.
17. Ifergan, I., Kebir, H., Alvarez, J. I., Marceau, G., Bernard, M., Bourbonniere, L., Poirier, J. et al., Central nervous system recruitment of effector memory CD8+ T lymphocytes during neuroinflammation is dependent on alpha4 integrin. Brain 2011. 134: 3560-3577.
18. Young, K. G., Maclean, S., Dudani, R., Krishnan, L. and Sad, S., CD8+ T cells primed in the periphery provide time-bound immune-surveillance to the central nervous system. J. Immunol. 2011. 187: 1192-1200.
19. Scheikl, T., Pignolet, B., Dalard, C., Desbois, S., Raison, D., Yamazaki, M., Saoudi, A. et al., Cutting edge: neuronal recognition by CD8 T cells elicits central diabetes insipidus. J. Immunol. 2012. 188: 4731-4735.
20. Elices, M. J., Osborn, L., Takada, Y., Crouse, C., Luhowskyj, S., Hemler, M. E. and Lobb, R. R., VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 1990. 60: 577-584.
21. Ludwig, R. J., Hardt, K., Hatting, M., Bistrian, R., Diehl, S., Radeke, H. H., Podda, M. et al., Junctional adhesion molecule (JAM)-B supports lymphocyte rolling and adhesion through interaction with alpha4beta1 integrin. Immunology 2009. 128: 196-205.
22. Luo, B. H., Carman, C. V. and Springer, T. A., Structural basis of integrin regulation and signaling. Annu. Rev. Immunol. 2007. 25: 619-647.
23. Haanstra, K. G., Hofman, S. O., Lopes Estevao, D. M., Blezer, E. L., Bauer, J., Yang, L. L., Wyant, T. et al., Antagonizing the alpha4beta1 integrin, but not alpha4beta7, inhibits leukocytic infiltration of the central nervous system in rhesus monkey experimental autoimmune encephalomyelitis. J. Immunol. 2013. 190: 1961-1973.
24. Doring, A., Pfeiffer, F., Meier, M., Dehouck, B., Tauber, S., Deutsch, U. and Engelhardt, B., TET inducible expression of the alpha4beta7-integrin ligand MAdCAM-1 on the blood-brain barrier does not influence the immunopathogenesis of experimental autoimmune encephalomyelitis. Eur. J. Immunol. 2011. 41: 813-821.
25. Laschinger, M. and Engelhardt, B., Interaction of alpha4-integrin with VCAM-1 is involved in adhesion of encephalitogenic T cell blasts to brain endothelium but not in their transendothelial migration in vitro. J. Neuroimmunol. 2000. 102: 32-43.
26. Steiner, O., Coisne, C., Cecchelli, R., Boscacci, R., Deutsch, U., Engelhardt, B. and Lyck, R., Differential roles for endothelial ICAM-1, ICAM-2, and VCAM-1 in shear-resistant T cell arrest, polarization, and directed crawling on blood-brain barrier endothelium. J. Immunol. 2010. 185: 4846-4855.
27. Jilek, S., Mathias, A., Canales, M., Lysandropoulos, A., Pantaleo, G., Schluep, M. and Du Pasquier, R. A., Natalizumab treatment alters the expression of T-cell trafficking marker LFA-1 alpha-chain (CD11a) in MS patients. Mult. Scler. 2013 [Epub ahead of print].
28. Schwab, N., Schneider-Hohendorf, T., Posevitz, V., Breuer, J., Gobel, K., Windhagen, S., Brochet, B. et al., L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients. Neurology 2013. 81: 865-871.
29. Berlin, C., Berg, E. L., Briskin, M. J., Andrew, D. P., Kilshaw, P. J., Holzmann, B., Weissman, I. L. et al., Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 1993. 74: 185-195.
30. Kamata, T., Puzon, W. and Takada, Y., Identification of putative ligand-binding sites of the integrin alpha 4 beta 1 (VLA-4, CD49d/CD29). Biochem. J. 1995. 305: 945-951.
31. Man, S., Tucky, B., Bagheri, N., Li, X., Kochar, R. and Ransohoff, R. M., Alpha4 Integrin/FN-CS1 mediated leukocyte adhesion to brain microvascular endothelial cells under flow conditions. J. Neuroimmunol. 2009. 210: 92-99.
32. van der Laan, L. J., van der Goes, A., Wauben, M. H., Ruuls, S. R., Dopp, E. A., De Groot, C. J., Kuijpers, T. W. et al., Beneficial effect of modified peptide inhibitor of alpha4 integrins on experimental allergic encephalomyelitis in Lewis rats. J. Neurosci. Res. 2002. 67: 191-199.
33. Cunningham, S. A., Rodriguez, J. M., Arrate, M. P., Tran, T. M. and Brock, T. A., JAM2 interacts with alpha4beta1. Facilitation by JAM3. J. Biol. Chem. 2002. 277: 27589-27592.
34. Martin-Padura, I., Lostaglio, S., Schneemann, M., Williams, L., Romano, M., Fruscella, P., Panzeri, C. et al., Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J. Cell Biol. 1998. 142: 117-127.
35. Del Maschio, A., De Luigi, A., Martin-Padura, I., Brockhaus, M., Bartfai, T., Fruscella, P., Adorini, L. et al., Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM). J. Exp. Med. 1999. 190: 1351-1356.
36. Lechner, F., Sahrbacher, U., Suter, T., Frei, K., Brockhaus, M., Koedel, U. and Fontana, A., Antibodies to the junctional adhesion molecule cause disruption of endothelial cells and do not prevent leukocyte influx into the meninges after viral or bacterial infection. J. Infect. Dis. 2000. 182: 978-982.
37. Aurrand-Lions, M., Johnson-Leger, C., Wong, C., Du Pasquier, L. and Imhof, B. A., Heterogeneity of endothelial junctions is reflected by differential expression and specific subcellular localization of the three JAM family members. Blood 2001. 98: 3699-3707.
38. Polman, C. H., O'Connor, P. W., Havrdova, E., Hutchinson, M., Kappos, L., Miller, D. H., Phillips, J. T. et al., A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. 2006. 354: 899-910.
39. Bloomgren, G., Richman, S., Hotermans, C., Subramanyam, M., Goelz, S., Natarajan, A., Lee, S. et al., Risk of natalizumab-associated progressive multifocal leukoencephalopathy. N. Engl. J. Med. 2012. 366: 1870-1880.
40. Bonig, H., Wundes, A., Chang, K. H., Lucas, S. and Papayannopoulou, T., Increased numbers of circulating hematopoietic stem/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab. Blood 2008. 111: 3439-3441.
41. del Pilar Martin, M., Cravens, P. D., Winger, R., Frohman, E. M., Racke, M. K., Eagar, T. N., Zamvil, S. S. et al., Decrease in the numbers of dendritic cells and CD4+ T cells in cerebral perivascular spaces due to natalizumab. Arch. Neurol. 2008. 65: 1596-1603.
42. Perkins, M. R., Ryschkewitsch, C., Liebner, J. C., Monaco, M. C., Himelfarb, D., Ireland, S., Roque, A. et al., Changes in JC virus-specific T cell responses during natalizumab treatment and in natalizumab-associated progressive multifocal leukoencephalopathy. PLoS Pathog. 2012. 8: e1003014.
43. Warnke, C., Mausberg, A. K., Stettner, M., Dehmel, T., Nekrich, L., Meyer zu Horste, G., Hartung, H. P. et al., Natalizumab affects the T-cell receptor repertoire in patients with multiple sclerosis. Neurology 2013. 81: 1400-1408.
44. Schneider-Hohendorf, T., Rossaint, J., Mohan, H., Boning, D., Breuer, J., Kuhlmann, T., Gross, C. C. et al., VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells. J. Exp. Med. 2014. 211: 1833-1846.
45. Stuve, O., Marra, C. M., Jerome, K. R., Cook, L., Cravens, P. D., Cepok, S., Frohman, E. M. et al., Immune surveillance in multiple sclerosis patients treated with natalizumab. Ann. Neurol. 2006. 59: 743-747.
46. Gasnault, J., Kahraman, M., de Goer de Herve, M. G., Durali, D., Delfraissy, J. F. and Taoufik, Y., Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy. AIDS 2003. 17: 1443-1449.
47. Du Pasquier, R. A., Schmitz, J. E., Jean-Jacques, J., Zheng, Y., Gordon, J., Khalili, K., Letvin, N. L. et al., Detection of JC virus-specific cytotoxic T lymphocytes in healthy individuals. J. Virol. 2004. 78: 10206-10210.
48. Tan, I. L., McArthur, J. C., Clifford, D. B., Major, E. O. and Nath, A., Immune reconstitution inflammatory syndrome in natalizumab-associated PML. Neurology 2011. 77: 1061-1067.
49. Aly, L., Yousef, S., Schippling, S., Jelcic, I., Breiden, P., Matschke, J., Schulz, R. et al., Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome. Brain 2011. 134: 2687-2702.
50. Metz, I., Radue, E. W., Oterino, A., Kumpfel, T., Wiendl, H., Schippling, S., Kuhle, J. et al., Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy. Acta Neuropathol. 2012. 123: 235-245.
51. Martin-Blondel, G., Bauer, J., Cuvinciuc, V., Uro-Coste, E., Debard, A., Massip, P., Delisle, M. B. et al., In situ evidence of JC virus control by CD8+ T cells in PML-IRIS during HIV infection. Neurology 2013. 81: 964-970.
52. Morgan, D. J., Liblau, R., Scott, B., Fleck, S., McDevitt, H. O., Sarvetnick, N., Lo, D. et al., CD8(+) T cell-mediated spontaneous diabetes in neonatal mice. J. Immunol. 1996. 157: 978-983.
53. Casanova, E., Fehsenfeld, S., Mantamadiotis, T., Lemberger, T., Greiner, E., Stewart, A. F. and Schutz, G., A CamKIIalpha iCre BAC allows brain-specific gene inactivation. Genesis 2001. 31: 37-42.
54. Saxena, A., Bauer, J., Scheikl, T., Zappulla, J., Audebert, M., Desbois, S., Waisman, A. et al., Cutting edge: multiple sclerosis-like lesions induced by effector CD8 T cells recognizing a sequestered antigen on oligodendrocytes. J. Immunol. 2008. 181: 1617-1621.
55. Vizler, C., Bercovici, N., Heurtier, A., Pardigon, N., Goude, K., Bailly, K., Combadiere, C. et al., Relative diabetogenic properties of islet-specific Tc1 and Tc2 cells in immunocompetent hosts. J. Immunol. 2000. 165: 6314-6321.
56. Wyss, L., Schafer, J., Liebner, S., Mittelbronn, M., Deutsch, U., Enzmann, G., Adams, R. H. et al., Junctional adhesion molecule (JAM)-C deficient C57BL/6 mice develop a severe hydrocephalus. PLoS One 2012. 7: e45619.